Skip to main content
Advertisement
  • Loading metrics

Understanding barriers and facilitators to clinic attendance and medication adherence among adults with hypertensive urgency in Tanzania

  • Godfrey A. Kisigo ,

    Roles Formal analysis, Methodology, Writing – original draft, Writing – review & editing

    godfrey.kisigo@mitu.or.tz

    Affiliations Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania, Center for Global Health, Weill Cornell Medicine, New York, New York, United States of America

  • Onike C. Mcharo,

    Roles Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing

    Affiliation Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania

  • John L. Robert,

    Roles Formal analysis, Methodology, Writing – review & editing

    Affiliation Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania

  • Robert N. Peck,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Supervision, Writing – original draft, Writing – review & editing

    Affiliations Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania, Center for Global Health, Weill Cornell Medicine, New York, New York, United States of America

  • Radhika Sundararajan,

    Roles Conceptualization, Methodology, Supervision, Writing – review & editing

    Affiliations Center for Global Health, Weill Cornell Medicine, New York, New York, United States of America, Department of Emergency Medicine, Weill Cornell Medicine, New York, New York, United States of America

  • Elialilia S. Okello

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

    Affiliation Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania

Abstract

Hypertensive urgency is a major risk factor for cardiovascular events and premature deaths. Lack of medication adherence is associated with poor health outcomes among patients with hypertensive urgency in resource-limited settings. To inform the development of tailored interventions to improve health outcomes in this population, this study aimed at understanding facilitators and barriers to clinic attendance and medication adherence among Tanzanian adults with hypertensive urgency. We conducted in-depth interviews with 38 purposively selected participants from three groups: 1) patients with hypertension attending hypertension clinic, 2) patients with hypertension not attending hypertension clinic, and 3) clinic health workers. Interviews were conducted using a semi-structured guide which included open-ended questions with prompts to encourage detailed responses. In their narrative, patients and healthcare workers discussed 21 types of barriers/facilitators to clinic attendance and medication adherence: 12 common to both behaviors (traditional medicine, knowledge and awareness, stigma, social support, insurance, reminder cues, symptoms, self-efficacy, peer support, specialized care, social services, religious beliefs); 6 distinct to clinic attendance (transport, clinic location, appointment, patient-provider interaction, service fragmentation, quality of care); and 3 distinct to medication adherence (drug stock, side effects, medicine beliefs). The majority of identified barriers/facilitators overlap between clinic attendance and medication adherence. The identified barriers may be surmountable using tailored supportive intervention approaches, such as peer counselors, to help patients overcome social challenges of clinic attendance and medication adherence.

Introduction

Hypertension affects nearly 1 billion adults worldwide and is the single most significant risk factor for premature mortality globally [1, 2]. In Tanzania, the prevalence of hypertension is high in both urban and rural areas [3], but only 20% of Tanzanian adults with hypertension are aware of their diagnosis, and among these, less than 1% are controlled [4]. As a result, adults with untreated or uncontrolled hypertension develop complications, including hypertensive urgency [5]—defined as a blood pressure >180/120 mmHg without new or progressive target organ damage. This complication is a major risk factor for cardiovascular events and mortality [6, 7].

In Tanzania, we have documented that 20% of patients with hypertensive urgency were hospitalized and 26% died within 6 months of being seen in the outpatient clinic [8]. Participants at the highest risk of poor outcomes were those who self-reported non-adherence to antihypertensive medications at the time of enrollment. These findings highlighted the urgent need for tailored intervention to improve clinic attendance and medication adherence so as to improve long-term outcomes in patients with hypertensive urgency [9].

However, evidence to inform interventions to improve hypertension treatments among adults presenting with hypertensive urgency is lacking. Several studies have elicited barriers and enablers to hypertension care in Sub-Saharan Africa (SSA), but none focused on patients with hypertensive urgency [1014]. We need to better understand the perspective of patients with hypertensive urgency in Africa and their healthcare providers in order to design targeted interventions to help patients with hypertensive urgency. Therefore, this study aimed at understanding factors that drive and inhibit clinic attendance and medication adherence among Tanzanian adults with hypertensive urgency as reported by patients and healthcare providers.

Methods

Overview

This study was part of formative research to inform intervention design for adult patients with hypertensive urgency attending outpatient clinic in Mwanza, Tanzania. The study purposively selected 38 individuals relevant to outpatient care of hypertensive urgency to complete in-depth interviews. The development of semi-structured interview guides and qualitative data analysis were guided by the Andersen’s Behavioral Model of Health Services Use (ABMHSU) [15], which is introduced succinctly below.

Theoretical framework

The ABMHSU provides a theoretical framework for understanding how patient and environmental factors impacts health behaviors and outcomes. These factors can be grouped into seven domains: patient characteristics (predisposing characteristics, enabling factors, perceived need), health care system environment (system, clinic, provider) and external environment (Fig 1). Multiple studies have used the ABMHSU to evaluate the use of health services among patients with chronic illness for purposes of identifying resolvable barriers to service utilizations in order to develop interventions to improve outcomes [1618].

thumbnail
Fig 1. The Andersen’s behavioral model of health services use (adapted from Andersen) [15].

https://doi.org/10.1371/journal.pgph.0000919.g001

In this study, we define predisposing factors as those factors that influence decision-making about hypertension, including attitudes, knowledge, and perceived control. Enabling factors included having appropriate community and individual-level resources necessary for accessing care. The perceived needs domain was defined as how individuals view their own health and functional state, which can be influenced positively or negatively by their perceived severity of health. The health care environment entails primary elements of healthcare services that create the health care environment for the patient. Finally, the external environment includes physical, political, and economic factors unrelated to the health care environment.

Study site and setting

This qualitative study was conducted as part of a larger study to develop an outpatient intervention to improve care among adults with hypertensive urgency. We conducted 38 qualitative interviews with three stakeholder groups relevant to the outpatient care for hypertensive urgency: 1) hypertensive urgency patients who have successfully attended the outpatient clinic; 2) hypertensive urgency patients who have not attended the clinic, and 3) healthcare workers. These interviews explored facilitators and barriers to outpatient clinic attendance and anti-hypertensive medication adherence. Data collection occurred between March and May 2020. The study received ethical approval from the Weill Cornell Medicine [Ref: 19–11021145] and the Tanzanian National Institute for Medical Research [Ref: NIMR/HQ/R.8a/Vol. IX/3349].

The study was conducted in the outpatient medical clinics of three hospital facilities in Mwanza City, Tanzania. The three study sites all together serve approximately 3000 adults living with hypertension annually. All clinics were following the national guidelines for treating hypertension [19]. Anti-hypertensive medications are widely available and inexpensive by high-income countries’ standards but can still be cost-prohibitive for most Tanzanians who live on <$100/month. Patients pay for services through a combination of insurance, government subsidy, and out-of-pocket contributions.

Participants

Outpatients with hypertensive urgency were eligible to participate in the study if they were aged 18 years and above, fluent in Swahili, and able to provide informed consent. Patients with hypertension were categorized as not attending the outpatient clinic if they missed clinic appointments for >3 months. Healthcare workers were invited to participate in the study if they worked in the outpatient hypertension clinic at one of the three hospitals where participants were recruited.

Procedures

Hypertensive urgency patients and healthcare workers were recruited at the clinic by the study team. Hypertensive urgency patients were selected focusing on their experience with hypertension urgency, either being a frequent attainder or non-attainders of the clinic. Non-attainders were identified from the previous cohort study of hypertensive patients conducted by RNP in the same hospital facilities of the current study. To establish non-attendance for >3 months, we assessed data on self-reported medication adherence and reviewed the medical record of clinic attendance. All participants in the previous cohort had contact information and provided their preferences on how they could be reached for future follow-up. Using the contact information extracted from patient files, the health worker contacted potential participants to provide brief information about the study.

All potential participants interested in joining the study were referred to the study team to receive additional information, confirm eligibility, and complete written informed consent procedures. Upon enrollment, participants were invited to schedule a time and choose their preferred location for the interview. Face-to-face interviews were conducted in Swahili, by trained Tanzanian researchers who had prior experience with qualitative research and had no affiliation with the clinic providing the hypertension care. Interviews took approximately one hour and were audio-recorded with the participant’s consent. Participants were given an incentive of 5000 Tanzanian Shillings (approximately $2.50) per interview. Following the completion of the interview, the audio files were transcribed and translated verbatim into English by research assistants fluent in both English and Swahili.

Data collection instrument

The development of the interview guide was informed by the ABMHSU (see Fig 1) described above. The guide included open-ended questions and probes related to facilitators and barriers to hypertension care. Each section of the guide began with an opening question, followed by potential probes to be used to explore the topic in greater depth. Examples of questions include “What are the things that have enabled you to come to your hypertension clinic visits and take your hypertensive medications?”, “What are the barriers you have faced attending your clinic appointments?” and “How do you think patients feel about services provided at the outpatient hypertension clinic?” The guide was contextualized according to the patient’s status (i.e., attending or not attending clinic) and healthcare worker occupation (e.g., doctor, nurse). The semi-structured guides were piloted among three hypertensive patients and two healthcare workers prior to the commencement of data collection; data from these pilot interviews were not included in the analysis.

Analysis

Data were analyzed using principles of applied thematic analysis [20] and consensual qualitative research [21]. Two team members [GAK, EO] independently reviewed transcripts to generate preliminary codes, which informed the development of a structured codebook focused on identifying the facilitators and barriers to clinic attendance and medication adherence. The 38 transcripts were uploaded to NVivo version 12 [22] and coded independently by two team members [OM, GAK] using the final codebook. After coding, code-level queries were run, analytic memos were written to synthesize the content and make comparisons across participant groups. These memos followed an established template of ABMHSU domains to extract and synthesize the core meaning from text related to each theme and to identify representative quotes. In writing memos, barriers and facilitators were analyzed as “barriers/facilitators” because participants’ discussions about clinic attendance and medication adherence behaviors often included their challenges and successes. At each step, coding team members [OM, GAK, and EO] returned to the original data to ensure that participants’ narratives and perspectives were retained. Disagreements were discussed until consensus was reached.

Results

Characteristic of study participants

A total of 38 participants participated in in-depth interviews; their ages ranged from 28 years to 77 years. An overview of the demographic information of the study participants can be found in Table 1.

thumbnail
Table 1. Participant’s socio-demographic characteristics.

https://doi.org/10.1371/journal.pgph.0000919.t001

In their narrative, patients and healthcare workers discussed 21 types of barriers/facilitators to clinic attendance and medication adherence: 12 common to both behaviours, 6 distinct to clinic attendance, and 3 distinct to medication adherence (Table 2).

thumbnail
Table 2. Barriers/facilitators affecting clinic attendance and medication adherence.

https://doi.org/10.1371/journal.pgph.0000919.t002

Barriers/facilitators are presented based on the ABMHSU patient (predisposing characteristics, enabling factors, and perceived need) and environment (health system, clinic, and provider) domains (Fig 2). Tables 3 and 4 report barriers/facilitators with illustrative core ideas. S1 Table highlights detailed description of barriers and facilitators as identified by the study participants.

thumbnail
Fig 2. Barriers and facilitators for clinic attendance and medication adherence among hypertensive urgency patients in Tanzania.

https://doi.org/10.1371/journal.pgph.0000919.g002

thumbnail
Table 3. Patient-level barriers/facilitators to clinic attendance and medication adherence organized according to the domains of the Andersen’s behavioral model of health services use.

https://doi.org/10.1371/journal.pgph.0000919.t003

thumbnail
Table 4. Environmental barriers/facilitators to clinic attendance and medication adherence organized according to the domains of the Andersen’s behavioral model of health services use.

https://doi.org/10.1371/journal.pgph.0000919.t004

Patient characteristics

Predisposing characteristics.

Patients and healthcare workers reported five barriers/facilitators under the predisposing characteristics domain. These barriers/facilitators were traditional medicine, religious beliefs, medicine beliefs, knowledge and awareness of hypertension, and stigma. Among these, traditional medicines were frequently reported as an alternative to allopathic medicine by patients, and they were identified as a critical barrier to clinic attendance and medication adherence by healthcare workers. In this context, we refer to traditional medicine as remedies made from plants prescribed by traditional healers. The preferential use of traditional medicine was primarily driven by the belief that hypertension is caused by witchcraft. Also, traditional medicines are low-priced and could be used for a short period compared to expensive, lifelong allopathic medicine. In this manner, traditional medicines were perceived as curative for hypertension instead of allopathic medicines that are lifelong. Furthermore, some patients reported that traditional medicines were more accessible and perceived to be more efficacious than allopathic medicine.

Most healthcare providers pointed out that solid religious belief in healing hypertension by prayer was a barrier to clinic attendance and medication adherence. Because of this belief, patients with hypertension were likely to stop attending clinics and quit using medicines prescribed by their healthcare providers.

Some patients described medicine beliefs as a barrier to medication adherence. It was believed that long-term use of hospital medicine is harmful and could result in adverse health outcomes. For example, it was generally believed that diabetes in people with hypertension was directly linked to the longstanding use of antihypertensive medicine. This belief was linked to some patients’ decisions to use traditional medicine.

Healthcare workers discussed proper knowledge and hypertension awareness as important barriers/facilitators to clinic attendance and medication adherence. Patients with poor knowledge of the cause, symptoms, and treatment of hypertension were observed to have poor clinic attendance and medication adherence. Nevertheless, healthcare workers noted that patients who are aware of their hypertension status have excellent records on clinic attendance and report good adherence to anti-hypertensive medicine.

Although patients were aware of the importance of adhering to hypertensive medication, they pointed out the stigma attached to taking lifelong medicine. According to patients, the public perception of taking medication daily was associated with the treatment of HIV, making patients reluctant to attend a monthly clinic and adhere to the medication regimen.

Enabling factors.

According to interviewed patients and healthcare workers, five facilitators/barriers were designated to the enabling factors domain. These barriers/facilitators were social support, transport to clinic, health insurance, medication side effects, and reminder cues. The paragraphs below provide a brief description of each barrier/facilitator.

Most patients reported that social support facilitated clinic attendance and medication adherence. This support was mainly from their close family members such as a spouse, children, and other immediate relatives. The assistance from these family members was likely to be available when a patient can disclose their hypertension status to the family. Social supporters reminded the patient when to attend the clinic and take medication, escorted the patient to the clinic whenever needed, and provided financial and moral support.

Some patients, especially those living far from the outpatient clinic, reported the cost of traveling to and from the clinic as a significant barrier to clinic attendance. Patients without financial support could not navigate this challenge.

Both patients and healthcare workers noted that health insurance subscription was a critical facilitator to clinic attendance and medication adherence. The cost of treatment (i.e., consultation and investigation fees, medicine prices) was entirely covered by the health insurance. Thus, patients with insurance cover do not bear the burden of treatment costs, unlike patients without insurance subscriptions, whom most could not afford.

While hypertension can be safely treated in most individuals, side effects of drugs are relatively frequent and could have notable effects on quality of life. A few patients shared their experiences regarding the side effects of antihypertensive medicines that led to poor medication adherence.

Reminder cues were reported by patients and healthcare workers as a facilitator to clinic attendance and medication adherence. Patients used several methods to remember taking antihypertensive medicines, including setting alarms on mobile phones and putting pillboxes at the bedside. Similarly, healthcare workers called patients a day before to remind them about the upcoming clinic appointment.

Perceived need.

The analysis of the perceived need domain revealed two barriers/facilitators, including hypertension symptoms and perceived self-efficacy (i.e., belief about one’s ability to handle hypertension). According to healthcare providers, most patients diagnosed with hypertension deny the diagnosis mainly due to a lack of symptoms. As a result, most patients will not attend the clinic or take antihypertensive medicine because they believe they are not sick. On the contrary, patients who accepted the diagnosis and believed that they could handle hypertension reported attending the clinic regularly and had good adherence.

Health care environment

System factors.

Patients in our study identified three services that impacted their health care environment. These services were specialized care, drug stock, and social welfare services. The majority of the patients emphasized that services provided by specialized doctors enhanced clinic attendance and medication adherence. However, not all clinics had enough specialized doctors to attend to overflowing patients per clinic. Furthermore, patients observed that antihypertensive drugs were often out of stock at public clinics, where they are sold at a subsidized price. Therefore, the drug stock affected medication adherence, especially for those who could not afford to purchase drugs at private pharmacies. Lastly, the availability of social welfare services at the clinic facilitated clinic attendance and medication adherence. Among the services provided under the social welfare services were cost exemption for those who could afford treatment costs and a pre-identified group of patients or diseases.

Clinic factors.

Patients’ and healthcare workers’ narratives highlighted five clinic barriers/facilitators; clinic appointment, service fragmentation, clinic location, quality of care, and peer support. All of these barriers/facilitators, except peer support, were linked to clinic attendance alone. Most patients were given monthly clinic appointments for clinical evaluation and drug refills. Due to a shortage of healthcare workers, patients reported spending a significant time in the clinic, which affected their routine. Furthermore, service fragmentation at the clinic made it hard for patients to complete clinic appointments in time, especially unaccompanied elderly patients. Patients felt that organizing all services at one point would expedite service provision. A few patients reported that quality of care enhanced their clinic attendance. This observation was evidently among patients with health insurance at some clinics where patients with insurance were given differentiated care. Healthcare providers felt that incorporating peer support programs at the standard of care would increase clinic attendance and medication adherence. Thus, patients who had hypertensive urgency and managed to get blood pressure under control would be used to provide education to their peers.

Provider factors.

Some patients encountered incompetent health care providers who were incapable of meeting their needs during the monthly clinic visit. This interaction with incompetent providers resulted in the negative experience of using health care services available in the clinic. For example, patients mentioned that some health care providers are using offensive language and ignore their questions about hypertension. For some patients, this experience discouraged them from continuing to attend clinic appointments.

Discussion

Hypertensive urgency is common in clinics in Africa, and over 1/3 of adults with hypertensive urgency will either be hospitalized or die within one year after presenting with hypertensive urgency. Hospitalization and death in patients with hypertensive urgency are strongly linked with poor clinic attendance and poor medication adherence. This study used qualitative methods guided by ABMHSU to explore barriers/ facilitators to clinic attendance and medication adherence among adults with hypertension urgency. This study represents a necessary step in contextualizing barriers/facilitators to clinic attendance and medication adherence among adults with hypertension urgency in Mwanza to develop a context-appropriate intervention for this group.

Our data reflects 21 barriers/facilitators to clinic attendance and medication adherence among patients with hypertensive urgency. The majority (12 out of 21) of the barriers/facilitators affected both behaviors. This overlap of barriers/facilitators across behaviors in the care continuum has been observed in several studies that assessed barriers and facilitators to chronic disease care engagement [16, 17]. However, it is worth noting that the magnitude of the effect of the barrier/facilitator often differs between behaviors. For example, traditional medicine hampered medication adherence more than clinic attendance in this study. This finding may be useful in the design of intervention so that targeting a set of facilitators/barriers might improve clinic attendance and medication adherence. Nevertheless, there should be a recognition that some facilitators/barriers are related to only one behavior, such as medication side effects that affect adherence alone.

Findings from the current study show that beliefs about traditional medicines can act as barriers to clinic attendance and medication adherence. In this study, participants’ beliefs about traditional medicine’s availability, accessibility, and efficacy influenced help-seeking behavior for hypertension. Similar findings have been reported by previous studies of patients with hypertension in Tanzania, Columbia, South Africa and Nepal [2326]. Such finding shows the importance of asking about the history of the use of alternative, traditional, or supplemental therapy from patients during the clinical encounter as a missed opportunity to address not only the underlying beliefs in the efficacy of traditional medicine but also to further counsel the patients about the nature and course of HTN.

Fear about the effect of poisoning from long-term use of hospital medicine for hypertension was reported to affect medication adherence. A significant correlation between beliefs about medication was found among hypertensive patients in Ghana and Nigeria [27], with patients who were worried about the adverse effects of antihypertensive drugs less likely to be adherent to their medications. Qualitative studies in Pakistan [28], Malaysia [29], and Nigeria [30] found that lack of faith in hospital medicine and perceived side effects hindered adherence to antihypertensive medication. Improving patients’ knowledge and attitudes to hospital medications may empower patients to be more concerned about their health and hence more involved in their treatment.

The health providers and patients in this study reported the ability to afford HTN treatment as a significant barrier to medication adherence. For patients living below the poverty line, the cost of purchasing antihypertensive poses a substantial burden to themselves and their dependents. According to our study participants’ narratives, this burden triggers stress and affects their general wellbeing. Consultation fee and treatment cost exemption, having health insurance were identified as important facilitators. These findings are consistent with other studies [26, 30, 31]. Participants in our study also pointed out the distance to a health facility as an important barrier to clinic attendance and adherence to antihypertensive medication. Longer distance to health facility contributed to non-adherence of hypertensive patients in Ethiopia [32].

In our study, participants identified lack of symptoms as one of the reasons people with hypertensive urgency may not attend the clinic or take hypertensive medications. Studies in Nigeria, India and Congo have shown that the absence of symptoms significantly contributed to poor compliance to hypertensive therapy [3336].

Our data shows that lack of both emotional and material support was a major barrier to clinic attendance and medication adherence among people with hypertension urgency. Other studies have reported that an absence of family support has a strong negative effect on adherence among hypertensive patients in Ethiopia [37] and Nigeria [38]. Likewise, studies in Congo reported that patients who received support from family members, and particularly reminders about taking their medications, were more likely to be adherent to their antihypertensive medications [35, 39].

Health systems factors, including lack of specialists, cost of medication, length of the clinic visit, and the fragmented nature of services offered, were among the critical barriers to clinic attendance. Weak health systems have been identified as a significant obstacle in effectively responding to the rising burden of chronic conditions such as hypertension in developing countries [40]. Calls have been made to recognize and analyze the complex interactions between health systems and their effects on hypertension management in developing countries [41]. Factors such as confidence in the physician’s knowledge or ability have been found to be significantly related to medication adherence in developed countries. Studies have found dissatisfaction with the health services and treatment providers influenced adherence significantly among patients with hypertension [42, 43]. Hypertensive individuals who were satisfied with the care received are more likely to adhere to the proposed medication treatment. Inconvenient clinic operating hours, long waiting times have also been found to be inhibitors of adherence [44, 45].

In our study, traditional medicine was among the salient barriers to clinic attendance and medication adherence. Prospective intervention designs could consider engaging with traditional healers or educating traditional healers to improve adherence for people with hypertension in communities where concurrent traditional medicine use is common. Previous studies [4650] demonstrate that partnerships with traditional healers can improve health education for chronic diseases.

Strengths and limitations

This was a qualitative study aimed at examining context-specific barriers and facilitators to hypertension clinic attendance and adherence to antihypertension. The use of open-ended questions helped to gather rich information on participants’ views and experiences. Our participants included both patients attending and those that had defaulted on regular clinic attendance and medication as well as health service providers. Such triangulation of data sources helped provide an in-depth understanding of context-specific barriers and facilitators from different perspectives. However, some study limitations should be considered, including the exploratory nature of this qualitative study, and confinement to a small sample of patients and health workers in three health facilities limit the generalizability of our findings to other population.

Conclusion

The current study identified 21 barriers/facilitators to clinic attendance and medication adherence among patients with hypertensive urgency. The barriers to clinic attendance and medication adherence may be surmountable using tailored supportive intervention approaches, such as peer counsellors, to help patients overcome social challenges of clinic attendance and medication adherence.

Supporting information

S1 Table. Barriers/facilitators to clinic attendance and medication adherence, categorized by Andersen’s behavioral model of health services use domains.

https://doi.org/10.1371/journal.pgph.0000919.s001

(DOCX)

Acknowledgments

We are indebted to the study participants who generously shared their thoughts and experiences. Also, we are grateful for the input of Saidi Kapiga, a scientific director at the Mwanza Intervention Trials Unit, throughout the process of writing this manuscript.

References

  1. 1. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317: 165. pmid:28097354
  2. 2. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392: 1736–1788. pmid:30496103
  3. 3. Galson SW, Staton CA, Karia F, Kilonzo K, Lunyera J, Patel UD, et al. Epidemiology of hypertension in Northern Tanzania: a community-based mixed-methods study. BMJ Open. 2017/11/12. 2017;7: e018829. pmid:29127232
  4. 4. Kavishe B, Biraro S, Baisley K, Vanobberghen F, Kapiga S, Munderi P, et al. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Med. 2015;13: 126. pmid:26021319
  5. 5. Paini A, Aggiusti C, Bertacchini F, Agabiti Rosei C, Maruelli G, Arnoldi C, et al. Definitions and Epidemiological Aspects of Hypertensive Urgencies and Emergencies. High Blood Press Cardiovasc Prev. 2018/06/20. 2018;25: 241–244. pmid:29916180
  6. 6. Ghosh S, Kumar M. Prevalence and associated risk factors of hypertension among persons aged 15–49 in India: a cross-sectional study. BMJ Open. 2019;9: e029714. pmid:31848161
  7. 7. Patel P, Ordunez P, DiPette D, Escobar MC, Hassell T, Wyss F, et al. Improved Blood Pressure Control to Reduce Cardiovascular Disease Morbidity and Mortality: The Standardized Hypertension Treatment and Prevention Project. J Clin Hypertens (Greenwich). 07/04. 2016;18: 1284–1294. pmid:27378199
  8. 8. Reis KG, Wilson R, Kalokola F, Wajanga B, Lee MH, Safford M, et al. Hypertensive Urgency in Tanzanian Adults: A 1-Year Prospective Study. Am J Hypertens. 2020/08/11. 2020;33: 1087–1091. pmid:32776154
  9. 9. Masenga SK, Sijumbila G. Hypertensive Urgency in Low- and Middle-Income Countries. Am J Hypertens. 2020/08/20. 2020;33: 1084–1086. pmid:32812019
  10. 10. Chang H, Hawley NL, Kalyesubula R, Siddharthan T, Checkley W, Knauf F, et al. Challenges to hypertension and diabetes management in rural Uganda: a qualitative study with patients, village health team members, and health care professionals. Int J Equity Health. 2019;18: 38. pmid:30819193
  11. 11. Gebrezgi MT, Trepka MJ, Kidane EA. Barriers to and facilitators of hypertension management in Asmara, Eritrea: patients’ perspectives. J Heal Popul Nutr. 2017/04/15. 2017;36: 11. pmid:28407794
  12. 12. Herskind J, Zelasko J, Bacher K, Holmes D. The outpatient management of hypertension at two Sierra Leonean health centres: A mixed-method investigation of follow-up compliance and patient-reported barriers to care. Afr J Prim Heal Care Fam Med. 2020/07/08. 2020;12: e1–e7. pmid:32634014
  13. 13. Manavalan P, Minja L, Wanda L, Hertz JT, Thielman NM, Okeke NL, et al. “It’s because I think too much”: Perspectives and experiences of adults with hypertension engaged in HIV care in northern Tanzania. PLoS One. 2020;15: e0243059. pmid:33270765
  14. 14. Nyaaba GN, Masana L, de-Graft Aikins A, Beune E, Agyemang C. Factors hindering hypertension control: perspectives of front-line health professionals in rural Ghana. Public Health. 2020/01/11. 2020;181: 16–23. pmid:31923796
  15. 15. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Heal Soc Behav. 1995/03/01. 1995;36: 1–10. pmid:7738325
  16. 16. Holtzman CW, Shea JA, Glanz K, Jacobs LM, Gross R, Hines J, et al. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen’s Behavioral Model. AIDS Care. 2015/02/12. 2015;27: 817–828. pmid:25671515
  17. 17. Rachlis B, Naanyu V, Wachira J, Genberg B, Koech B, Kamene R, et al. Identifying common barriers and facilitators to linkage and retention in chronic disease care in western Kenya. BMC Public Health. 2016;16: 741. pmid:27503191
  18. 18. Rachlis B, Naanyu V, Wachira J, Genberg B, Koech B, Kamene R, et al. Community Perceptions of Community Health Workers (CHWs) and Their Roles in Management for HIV, Tuberculosis and Hypertension in Western Kenya. Siedner MJ, editor. PLoS One. 2016;11: e0149412. pmid:26901854
  19. 19. MoHCDEC. Standard Treatment Guidelines and Essential Medicines lists for children and adolescents. Ministry of Health CDE and C, editor. Dar-Es-Salaam, TZ: Tanzania, Ministry of Health, Community Development Elderly and Children; 2018.
  20. 20. Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS One. 2020;15: e0232076. pmid:32369511
  21. 21. Hill CE, Thompson BJ, Williams EN. A Guide to Conducting Consensual Qualitative Research. Couns Psychol. 1997;25: 517–572.
  22. 22. Ltd QSRIP. NVivo (released in March 2020), https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home; 2020.
  23. 23. Mothiba TM, Malema RN, Lekhuleni ME. The experiences of the newly diagnosed hypertensive patients admitted into tertiary hospital campus in Limpopo Province, South Africa. African J Phys Heal Educ Recreat Danc. 2013;19: 213–221.
  24. 24. Liwa A, Roediger R, Jaka H, Bougaila A, Smart L, Langwick S, et al. Herbal and Alternative Medicine Use in Tanzanian Adults Admitted with Hypertension-Related Diseases: A Mixed-Methods Study. Schlaich MP, editor. Int J Hypertens. 2017;2017: 5692572. pmid:28634545
  25. 25. Bhandari B, Bhattarai M, Bhandari M, Ghimire A, Pokharel PK, Morisky DE. Adherence to Antihypertensive Medications: Population Based Follow up in Eastern Nepal. J Nepal Heal Res Counc. 2015/09/29. 2015;13: 38–42. pmid:26411711
  26. 26. Legido-Quigley H, Camacho Lopez PA, Balabanova D, Perel P, Lopez-Jaramillo P, Nieuwlaat R, et al. Patients’ Knowledge, Attitudes, Behaviour and Health Care Experiences on the Prevention, Detection, Management and Control of Hypertension in Colombia: A Qualitative Study. PLoS One. 2015;10: e0122112. pmid:25909595
  27. 27. Boima V, Ademola AD, Odusola AO, Agyekum F, Nwafor CE, Cole H, et al. Factors Associated with Medication Nonadherence among Hypertensives in Ghana and Nigeria. Int J Hypertens. 2015/10/29. 2015;2015: 205716. pmid:26509081
  28. 28. Saleem F, Hassali M, Shafie A, Atif M. Drug attitude and adherence: a qualitative insight of patients with hypertension. J Young Pharm. 2012;4: 101–107. pmid:22754262
  29. 29. Shima R, Farizah MH, Majid HA. A qualitative study on hypertensive care behavior in primary health care settings in Malaysia. Patient Prefer Adherence. 2014;8: 1597–1609. pmid:25484577
  30. 30. Fongwa MN, Evangelista LS, Hays RD, Martins DS, Elashoff D, Cowan MJ, et al. Adherence treatment factors in hypertensive African American women. Vasc Health Risk Manag. 2008;4: 157–66. pmid:18629350
  31. 31. Jolles EP, Padwal RS, Clark AM, Braam B. A Qualitative Study of Patient Perspectives about Hypertension. ISRN Hypertens. 2013;2013: 1–10.
  32. 32. Gelaw BK, Gelaw YK. Assessment of Adherence of Patients with Anti- Hypertensive Medication and Factors for Non- Adherence in Amhara Region Dessie Referral Hospital, Ethiopia. 2014.
  33. 33. Campbell PC, Oladeyi OO. Compliance To and Knowledge of Anti-Hypertensive Therapy amongst Hypertensive Patients Attending Lagos University Teaching Hospital (Luth), Idi-Araba, Lagos, Nigeria. IOSR J Dent Med Sci. 2014;13: 108–115.
  34. 34. Kusuma YS. Migrants’ Perceptions on Barriers to Treatment Seeking for Hypertension: A Qualitative Study from Delhi, India. Stud Ethno-Medicine. 2010;4: 173–176.
  35. 35. Fina Lubaki J-P, Mabuza L, Malete N, Maduna P, Ndimande J V. Reasons for non-compliance among patients with hypertension at Vanga Hospital, Bandundu Province, Democratic Republic of Congo: A qualitative study. African J Prim Heal Care Fam Med. 2009;1.
  36. 36. Nagarkar AM, Gadhave SA, Sharma I, Choure A, Morisky D. Factors Influencing Medication Adherence Among Hypertensive Patients in a Tertiary Care Hospital, Pune, Maharashtra. Natl J Community Med. 2013;4: 559–563.
  37. 37. Ali M, Bekele M, Teklay G. Antihypertensive medication non-adherence and its determinants among patients on follow up in public hospitals in Northern Ethiopia. Int J Clin Trials. 2014;1: 95.
  38. 38. Olowookere A, Olowookere S, Talabi A, Etonyeaku A, Adeleke O, Akinboboye O. Perceived family support and factors influencing medication adherence among hypertensive patients attending a Nigerian tertiary hospital. Ann Trop Med Public Heal. 2015;8: 241.
  39. 39. Mesmer NSITOU B, Stéphane IKAMA M, Drame B, Bwira Kaboru B. Global Journal of Medicine and Public Health Patients-related predictors of poor adherence to antihypertensive treatment in Congo-Brazzaville: a cross-sectional study. Glob J Med Glob Heal Kaboru, B Glob J Med Glob Heal www.gjmedph.org. 2013;2: 1–9.
  40. 40. Maimaris W, Paty J, Perel P, Legido-Quigley H, Balabanova D, Nieuwlaat R, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med. 2013;10: e1001490. pmid:23935461
  41. 41. Chia LR, Schlenk EA, Dunbar-Jacob J. Effect of personal and cultural beliefs on medication adherence in the elderly. Drugs Aging. 2006;23: 191–202. pmid:16608375
  42. 42. Al-Ramahi R. Adherence to medications and associated factors: A cross-sectional study among Palestinian hypertensive patients. J Epidemiol Glob Health. 2015;5: 125–32. pmid:25922321
  43. 43. Zyoud SH, Al-Jabi SW, Sweileh WM, Morisky DE. Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Qual Life Outcomes. 2013;11: 191. pmid:24195638
  44. 44. Mahmoudian A, Zamani A, Tavakoli N, Farajzadegan Z, Fathollahi-Dehkordi F. Medication adherence in patients with hypertension: Does satisfaction with doctor-patient relationship work? J Res Med Sci. 2017;22: 48. pmid:28567067
  45. 45. Barbosa CD, Balp M-M, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 01/13. 2012;6: 39–48. pmid:22272068
  46. 46. Kayombo EJ, Mbwambo ZH, Massila M. Role of traditional healers in psychosocial support in caring for the orphans: a case of Dar-es Salaam City, Tanzania. J Ethnobiol Ethnomed. 2005;1: 3. pmid:16270914
  47. 47. Akol A, Moland KM, Babirye JN, Engebretsen IMS. “We are like co-wives”: Traditional healers’ views on collaborating with the formal Child and Adolescent Mental Health System in Uganda. BMC Health Serv Res. 2018;18: 258. pmid:29631632
  48. 48. Gureje O, Appiah-Poku J, Bello T, Kola L, Araya R, Chisholm D, et al. Effect of collaborative care between traditional and faith healers and primary health-care workers on psychosis outcomes in Nigeria and Ghana (COSIMPO): a cluster randomised controlled trial. Lancet (London, England). 2020;396: 612–622. pmid:32861306
  49. 49. Schausberger B, Mmema N, Dlamini V, Dube L, Aung A, Kerschberger B, et al. “We have to learn to cooperate with each other”: a qualitative study to explore integration of traditional healers into the provision of HIV self-testing and tuberculosis screening in Eswatini. BMC Health Serv Res. 2021;21: 1314. pmid:34872563
  50. 50. Sundararajan R, Ponticiello M, Lee MH, Strathdee SA, Muyindike W, Nansera D, et al. Traditional healer-delivered point-of-care HIV testing versus referral to clinical facilities for adults of unknown serostatus in rural Uganda: a mixed-methods, cluster-randomised trial. Lancet Glob Heal. 2021;9: e1579–e1588. pmid:34678199